Lyka Labs P/B Ratio

LYKALABS • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
2.86
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Current Valuation Metrics

P/B Ratio 2.86
Current Price ₹78.04
Book Value/Share ₹28.89
Exchange NSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹104 Cr
Share Capital ₹36 Cr
Reserves & Surplus ₹68 Cr
Outstanding Shares 36,000,000
Book Value per Share ₹28.89

Valuation Signal

Signal Overvalued
Historical Avg 11.38
Historical Range 2.63 - 26.87
Percentile 25.0%

Sector Context

Sector Average -0.1
Sector Median 0.66
Sector Rank #11 of 50
Sector Percentile 22.0%

Key P/B Ratio Insights for Lyka Labs

  • Current PB is 74.9% below historical average
  • Trading at premium to sector average PB of -0.1

View the current stock price of Lyka Labs for more insights.

P/B Ratio Historical Trend for Lyka Labs

Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.

Historical P/B Ratio Data

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 2.63 ₹28.89 ₹75.89 ₹104 Moderate
2024 7.66 ₹20.61 ₹157.82 ₹68 High
2023 8.34 ₹14.84 ₹123.75 ₹46 High
2022 26.87 ₹4.83 ₹129.70 ₹14 High

Sector P/B Ratio Comparison

Comparing Lyka Labs with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Sun Pharma Advanced Rese… SPARC -12.97 ₹4,391 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.47 ₹95 Low
Parmax Pharma PARMAX -2.15 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.96 ₹154 Low
Triochem Products TRIPR 0.04 ₹0 Low
Murae Organisor MURAE 0.26 ₹55 Low